About
The demand for wellness genomics has grown in response to increasing healthcare understanding and a change in population preference for a healthier lifestyle. The global wellness genomics market is expected to be driven by factors such as the government’s and other private regulatory bodies’ increased attention to public health care, increased efficacy & efficiency of genetic testing, and the prevalence of chronic diseases & genetic diseases such as Parkinson’s and cystic fibrosis during the forecast period. In addition, the growing need to understand one’s family background is driving the global market. However, strict regulatory rules and ethics for genetic testing approval could stifle the market’s growth. North America dominated the industry, followed by Europe. North America’s supremacy can be attributed to a number of factors, including its well-established healthcare system, high levels of literacy, the prevalence of chronic diseases, and rapid adoption of emerging technologies.